Dr. Michael Kurilla of the National Institute of Allergy and Infectious Diseases takes a look at the progression of Infectious Diseases, where vaccine and treatment trends may be heading, and NIAID’s role in addressing unmet needs.
Todd Merchak of the National Institute of Biomedical Imaging and Bioengineering discusses SBIR, STTR, and other grants available to support innovative R&D in medtech.
Dr. Mark Allegretta of the National MS Society shares on the Fast Forward program and their investment methods.
Evelia Johnston of The Michael J. Fox Foundation for Parkinson’s Research speaks about venture philanthropy and how the MJFF works to fulfill the unmet funding needs of R&D targeting Parkinson’s Disease.
Life Science Nation founder Dennis Ford gives insight into fundraising and tips for approaching investors.
Dr. Jak Knowles of CureDuchenne Ventures sheds light on Duchenne Muscular Dystrophy, CureDuchenne’s role in seeking a cure, and its non-dilutive and venture philanthropy funding models supporting R&D.
Venue: ETC Venues Location: London, United Kingdom Event Website The 2nd annual Biotech and Money London 2016 event is a two-day congress providing the education, strategies and solutions you need to enable more effective funding, investment, business planning and partnering within your business. HOW IT’S DIFFERENT A qualified executive-level only audience No CROs, CMOs or EQMs […]
As Europe’s leading investment and biopartnering conference, BioTrinity is the nexus of a booming life sciences innovation ecosystem and provides a unique platform for R&D, global pharma and investor companies across the life sciences industry to achieve their business objectives; to secure funding, seek acquisition and in-licensing deals and grow their network. BioTrinity is celebrating […]
The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, […]
Summit Overview – Join life science industry leaders in a full day of non-dilutive funding activities at the 11th Annual Non-dilutive Funding Summit, taking place on Wednesday January 13th, 2016 in San Francisco. REGISTRATION This year the summit is proud to host Colonel Russell E. Coleman, Ph.D., Joint Project Manager, Medical Countermeasure Systems Assistant Corps […]